[INQ. NO. 2110C56] The COVID-19 Ag Rapid Test is capable of testing whether or not the subject is infected with COVID-19 within 20 minutes by detecting the nucleoprotein of SARS-CoV-2 using a sample taken from the nasal cavity using a cotton swab.
It detects antibodies to the nucleoprotein and spike protein of SARS-CoV-2 generated after infection with a single drop of blood. Detection of COVID-19 is possible on the spot without any special equipment, and it secures ease of use and high specificity and sensitivity by using self-developed gold nanoparticles in addition to its raw materials.
Existing PCR in the market is designed to identify the gene of the virus to check the presence or absence of COVID-19 by amplifying the collected genes, which requires equipment such as testing laboratories and extraction machines and specialized personnel to handle them. The COVID-19 Ag Rapid Test can be used similarly to or more efficiently than PCR.

Founded in 2016, PRIME4DIA Co., Ltd. specializes in the development and production of vitro diagnostic products. Apart from COVID-19 Ag Rapid Test, it produces about 50 types of rapid diagnostic testers. Among which is a human Influenza A&B rapid diagnostic tester and a kit that can distinguish between COVID-19 and Influenza that has similar symptoms to COVID-19, as well as other infectious diseases such as HIV, dengue and malaria, rapid diagnostic tester and cancer diagnostic kits.

The company also produces the avian flu rapid diagnostic tester, as well as products to detect distemper, heartworm, and coronavirus in pets and livestock.

Korean-Products.com | Blog Magazine of Korean products, brands and Goods